reports
MOSL: DIVI'S LABORATORIES (Neutral)-US FDA clears Unit-2-positives alr...
​Divi's Laboratories: US FDA clears Unit-2; positives already priced in(DIVI IN, Mkt Cap USD4.4b, CMP INR1074, TP INR1100, 2% Upside, Neutral)​Divi's Laboratories (DIVI) announced that the US FDA will lift the import alert under clause 66-32 at the Vishakhapatnam-based Unit-2 facility. Exposure to the US market from Unit-2 stands at ~22% of total sales (pre-import alert). This has been one of the fastest resolutions post receipt of the import alert in Mar-17.Import alert under clause 99-32 w...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.